Jagsonpal Pharmaceuticals standalone net profit rises 53.41% in the September 2024 quarter

Net profit of Jagsonpal Pharmaceuticals rose 53.41% to Rs 11.46 crore in the quarter ended September 2024 as against Rs 7.47 crore during the previous quarter ended September 2023. Sales rose 29.15% to Rs 74.69 crore in the quarter ended September 2024 as against Rs 57.83 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	74.69	57.83	29
OPM %	21.81	14.47	-
PBDT	17.71	10.42	70
PBT	15.37	9.96	54
NP	11.46	7.47	53